You are invited to a CME Symposium

Urgency is considered to be the primary symptom in OAB, yet inconsistencies remain both in its definition and how it is measured. Clinical studies of urgency often comprise different patient populations, and numerous tools are used to measure outcomes in these studies.

To complicate matters, little is known about the pathophysiology of urgency, although recently more attention has been paid to urothelial-afferent communication and its possible impact on pharmacotherapy for OAB. These new insights into bladder functioning and its role for signaling regulatory processes are important for clinicians’ understanding of how medications and other therapies target different aspects of the bladder.

Recent flexible-dosing studies with antimuscarinics suggest that urge urinary and total incontinence episodes may be reduced significantly with a flexible-dosing strategy. Dose adjustment may improve the therapeutic outcome, facilitating a balance between efficacy and side effects.

This interactive symposium will bring together renowned thought leaders in the field of urology to discuss some of the most pressing issues in OAB today including new pathophysiologic insights, urgency, outcomes, and flexible dosing.

Target Audience

This activity is specially designed for urologists.